Parker Institute for Cancer Immunotherapy has named Karen E. Knudsen, MBA, PhD, as its new CEO, according to a press release.Knudsen most recently served as CEO of the American Cancer Society and its ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t ...

SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new chief executive officer.

Karen Knudsen, PhD, has been appointed CEO of San Francisco-based Parker Institute for Cancer Immunotherapy. Dr. Knudsen previously served as CEO for both the American Cancer Society and ACS Cancer ...